{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:34Z","timestamp":1793035714130,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0C8920N"],"award-info":[{"award-number":["G0C8920N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G060623N"],"award-info":[{"award-number":["G060623N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1804123N"],"award-info":[{"award-number":["1804123N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009155","name":"Otsuka America Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020295","name":"Natera","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00467-024-06652-7","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T07:13:38Z","timestamp":1738394018000},"page":"1997-2007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40"],"prefix":"10.1007","volume":"40","author":[{"given":"Stijn","family":"Wigerinck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Schellekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Dachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maroun","family":"Chedid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Hamid","family":"Borghol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Senum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Bockenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Jouret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad T.","family":"Chebib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-6088","authenticated-orcid":false,"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"6652_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2215\/CJN.05900519","volume":"15","author":"T Suwabe","year":"2020","unstructured":"Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, Senum SR, Madsen CD, Chebib FT, Hogan MC, Cornec-Le Gall E, Harris PC, Torres VE (2020) Epidemiology of autosomal dominant polycystic kidney disease in Olmsted County. Clin J Am Soc Nephrol 15:69\u201379. https:\/\/doi.org\/10.2215\/CJN.05900519","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329:332\u2013342. https:\/\/doi.org\/10.1056\/NEJM199307293290508","journal-title":"N Engl J Med"},{"key":"6652_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287\u20131301. https:\/\/doi.org\/10.1016\/S0140-6736(07)60601-1","journal-title":"Lancet"},{"key":"6652_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N, Dijk MAV, Bogdanova N, Coto E, Saggar-Malik AK, Millan JLS, Torra R, Breuning M, Ravine D (1999) Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353:103\u2013107. https:\/\/doi.org\/10.1016\/s0140-6736(98)03495-3","journal-title":"Lancet"},{"key":"6652_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Ferec C, Le Meur Y (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006\u20131013. https:\/\/doi.org\/10.1681\/ASN.2012070650","journal-title":"J Am Soc Nephrol"},{"key":"6652_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1681\/ASN.2015010016","volume":"27","author":"E Cornec-Le Gall","year":"2016","unstructured":"Cornec-Le Gall E, Audrezet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Ferec C, Le Meur Y (2016) The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 27:942\u2013951. https:\/\/doi.org\/10.1681\/ASN.2015010016","journal-title":"J Am Soc Nephrol"},{"key":"6652_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1053\/j.ajkd.2017.01.046","volume":"70","author":"E Cornec-Le Gall","year":"2017","unstructured":"Cornec-Le Gall E, Audr\u00e9zet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecoti\u00e8re L, Bridoux F, Mandart L, Hanrotel-Saliou C, Stanescu C, Depraetre P, Gie S, Massad M, Kersal\u00e9 A, S\u00e9ret G, Augusto JF, Saliou P, Maestri S, Chen JM, Harris PC, F\u00e9rec C, Le Meur Y (2017) PKD2-related autosomal dominant polycystic kidney disease: prevalence, clinical presentation, mutation spectrum, and prognosis. Am J Kidney Dis 70:476\u2013485. https:\/\/doi.org\/10.1053\/j.ajkd.2017.01.046","journal-title":"Am J Kidney Dis"},{"key":"6652_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2215\/CJN.16871020","volume":"16","author":"KL Nowak","year":"2021","unstructured":"Nowak KL, Steele C, Gitomer B, Wang W, Ouyang J, Chonchol MB (2021) Overweight and obesity and progression of ADPKD. Clin J Am Soc Nephrol 16:908\u2013915. https:\/\/doi.org\/10.2215\/CJN.16871020","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR9","doi-asserted-by":"publisher","unstructured":"Claus LR, Chen C, Stallworth J, Turner JL, Slaats GG, Hawks AL, Mabillard H, Senum SR, Srikanth S, Flanagan-Steet H, Louie RJ, Silver J, Lerner-Ellis J, Morel C, Mighton C, Sleutels F, van Slegtenhorst M, van Ham T, Brooks AS, Dorresteijn EM, Barakat TS, Dahan K, Demoulin N, Goffin EJ, Olinger E; Genomics England Research Consortium; Larsen M, Hertz JM, Lilien MR, Obeidov\u00e1 L, Seeman T, Stone HK, Kerecuk L, Gurgu M, Yousef Yengej FA, Ammerlaan CME, Rookmaaker MB, Hanna C, Rogers RC, Duran K, Peters E, Sayer JA, van Haaften G, Harris PC, Ling K, Mason JM, van Eerde AM, Steet R (2023) Certain heterozygous variants in the kinase domain of the serine\/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease. Kidney Int 104:995-1007. https:\/\/doi.org\/10.1016\/j.kint.2023.07.021","DOI":"10.1016\/j.kint.2023.07.021"},{"key":"6652_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.kint.2022.11.025","volume":"103","author":"B Apple","year":"2023","unstructured":"Apple B, Sartori G, Moore B, Chintam K, Singh G, Anand PM, Strande NT, Mirshahi T, Triffo W, Chang AR (2023) Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease. Kidney Int 103:607\u2013615. https:\/\/doi.org\/10.1016\/j.kint.2022.11.025","journal-title":"Kidney Int"},{"key":"6652_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","volume":"98","author":"B Porath","year":"2016","unstructured":"Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Ba\u00f1ales JM, Hogan MC, Tasic V, Watnick TJ, Chapman AB, Vigneau C, Lavainne F, Audr\u00e9zet MP, Ferec C, Le Meur Y, Torres VE, Harris PC (2016) Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet 98:1193\u20131207. https:\/\/doi.org\/10.1016\/j.ajhg.2016.05.004","journal-title":"Am J Hum Genet"},{"key":"6652_CR12","doi-asserted-by":"publisher","unstructured":"Cornec-Le Gall E, Olson RJ, Besse W, Heyer CM, Gainullin VG, Smith JM, Audrezet MP, Hopp K, Porath B, Shi B, Baheti S, Senum SR, Arroyo J, Madsen CD, Ferec C, Joly D, Jouret F, Fikri-Benbrahim O, Charasse C, Coulibaly JM, Yu AS, Khalili K, Pei Y, Somlo S, Le Meur Y, Torres VE; Genkyst Study Group; HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease; Harris PC (2018) Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease. Am J Hum Genet 102:832-844. https:\/\/doi.org\/10.1016\/j.ajhg.2018.03.013","DOI":"10.1016\/j.ajhg.2018.03.013"},{"key":"6652_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","volume":"109","author":"SR Senum","year":"2022","unstructured":"Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audr\u00e9zet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le Gall E, Hogan MC, Torres VE, Sayer JA, Harris PC (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet 109:136\u2013156. https:\/\/doi.org\/10.1016\/j.ajhg.2021.11.016","journal-title":"Am J Hum Genet"},{"key":"6652_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26:160\u2013172. https:\/\/doi.org\/10.1681\/ASN.2013101138","journal-title":"J Am Soc Nephrol"},{"key":"6652_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fped.2017.00272","volume":"5","author":"S De Rechter","year":"2017","unstructured":"De Rechter S, Breysem L, Mekahli D (2017) Is autosomal dominant polycystic kidney disease becoming a pediatric disorder? Front Pediatr 5:272. https:\/\/doi.org\/10.3389\/fped.2017.00272","journal-title":"Front Pediatr"},{"key":"6652_CR16","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41598-020-61303-9","volume":"10","author":"P Janssens","year":"2020","unstructured":"Janssens P, Jouret F, Bammens B, Liebau MC, Schaefer F, Dandurand A, Perrone RD, Muller RU, Pao CS, Mekahli D (2020) Implications of early diagnosis of autosomal dominant polycystic kidney disease: a post hoc analysis of the TEMPO 3:4 trial. Sci Rep 10:4294. https:\/\/doi.org\/10.1038\/s41598-020-61303-9","journal-title":"Sci Rep"},{"key":"6652_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.ki.5002624","volume":"73","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ, Cook LT, Torres VE, Bost JE, Chapman AB, Harris PC, Guay-Woodford LM, Bae KT (2008) Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int 73:108\u2013116. https:\/\/doi.org\/10.1038\/sj.ki.5002624","journal-title":"Kidney Int"},{"key":"6652_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2215\/CJN.0000000000000022","volume":"18","author":"D Mekahli","year":"2023","unstructured":"Mekahli D, Guay-Woodford L, Cadnapaphornchai M, Greenbaum L, Litwin M, Seeman T, Dandurand A, Shi L, Sikes K, Shoaf S, Schaefer F (2023) Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease randomized controlled trial. Clin J Am Soc Nephrol 18:36\u201346. https:\/\/doi.org\/10.2215\/CJN.0000000000000022","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41390-020-0942-2","volume":"89","author":"R Raina","year":"2021","unstructured":"Raina R, Chakraborty R, DeCoy ME, Kline T (2021) Autosomal-dominant polycystic kidney disease: tolvaptan use in adolescents and young adults with rapid progression. Pediatr Res 89:894\u2013899. https:\/\/doi.org\/10.1038\/s41390-020-0942-2","journal-title":"Pediatr Res"},{"key":"6652_CR20","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/ckj\/sfy088","volume":"11","author":"S De Rechter","year":"2018","unstructured":"De Rechter S, Bammens B, Schaefer F, Liebau MC, Mekahli D (2018) Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective. Clin Kidney J 11:i14\u2013i26. https:\/\/doi.org\/10.1093\/ckj\/sfy088","journal-title":"Clin Kidney J"},{"key":"6652_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2215\/CJN.0000000000000122","volume":"18","author":"L Breysem","year":"2023","unstructured":"Breysem L, De Keyzer F, Schellekens P, Dachy A, De Rechter S, Janssens P, Vennekens R, Bammens B, Irazabal MV, Van Ongeval C, Harris PC, Mekahli D (2023) Risk severity model for pediatric autosomal dominant polycystic kidney disease using 3D ultrasound volumetry. Clin J Am Soc Nephrol 18:581\u2013591. https:\/\/doi.org\/10.2215\/CJN.0000000000000122","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR22","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","volume":"59","author":"GM Fick-Brosnahan","year":"2001","unstructured":"Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA (2001) Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59:1654\u20131662. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590051654.x","journal-title":"Kidney Int"},{"key":"6652_CR23","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.ekir.2023.06.018","volume":"8","author":"YK Oh","year":"2023","unstructured":"Oh YK, Ryu H, Qhn C, Park HC, Ma Y, Xu D, Ecder T, Kao T, Huang J, Rangan G, RAPID-ADPKD Study Group (2023) Clinical characteristics of rapid progression in Asia-Pacific patients with ADPKD. Kidney Int Rep 8:1801\u20131810. https:\/\/doi.org\/10.1016\/j.ekir.2023.06.018","journal-title":"Kidney Int Rep"},{"key":"6652_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0272-6386(12)80541-5","volume":"20","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Duley I, Johnson AM (1992) Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20:140\u2013143. https:\/\/doi.org\/10.1016\/s0272-6386(12)80541-5","journal-title":"Am J Kidney Dis"},{"key":"6652_CR25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/nep.13407","volume":"24","author":"H Kim","year":"2019","unstructured":"Kim H, Koh J, Park SK, Oh KH, Kim YH, Kim Y, Ahn C, Oh YK (2019) Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease. Nephrology (Carlton) 24:422\u2013429. https:\/\/doi.org\/10.1111\/nep.13407","journal-title":"Nephrology (Carlton)"},{"key":"6652_CR26","doi-asserted-by":"publisher","first-page":"c270","DOI":"10.1159\/000320745","volume":"117","author":"R Kazancioglu","year":"2011","unstructured":"Kazancioglu R, Ecder T, Altintepe L, Altiparmak MR, Tuglular S, Uyanik A, Cavdar C, Ecder SA, Tokgoz B, Duman N, Duzova A, Cetinkaya R (2011) Demographic and clinical characteristics of patients with autosomal dominant polycystic kidney disease: a multicenter experience. Nephron Clin Pract 117:c270\u2013c275. https:\/\/doi.org\/10.1159\/000320745","journal-title":"Nephron Clin Pract"},{"key":"6652_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/1319-2442.198163","volume":"28","author":"S Vikrant","year":"2017","unstructured":"Vikrant S, Parashar A (2017) Autosomal dominant polycystic kidney disease: study of clinical characteristics in an Indian population. Saudi J Kidney Dis Transpl 28:115\u2013124. https:\/\/doi.org\/10.4103\/1319-2442.198163","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"6652_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/qjmed\/hct082","volume":"106","author":"KM Thong","year":"2013","unstructured":"Thong KM, Ong AC (2013) The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. QJM 106:639\u2013646. https:\/\/doi.org\/10.1093\/qjmed\/hct082","journal-title":"QJM"},{"key":"6652_CR29","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.12659\/MSM.910127","volume":"24","author":"J Meng","year":"2018","unstructured":"Meng J, Xu Y, Li A, Fan S, Shen X, Ma D, Zhang L, Hao Z, Zhang X, Liang C (2018) Clinical features of 167 inpatients with autosomal dominant polycystic kidney disease at a single center in China. Med Sci Monit 24:6498\u20136505. https:\/\/doi.org\/10.12659\/MSM.910127","journal-title":"Med Sci Monit"},{"key":"6652_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2369-15-63","volume":"15","author":"M Han","year":"2014","unstructured":"Han M, Park HC, Kim H, Jo HA, Huh H, Jang JY, Kang AY, Kim SH, Cheong HI, Kang DH, Yang J, Oh KH, Hwang YH, Ahn C (2014) Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease. BMC Nephrol 15:63. https:\/\/doi.org\/10.1186\/1471-2369-15-63","journal-title":"BMC Nephrol"},{"key":"6652_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ekir.2023.02.1073","volume":"8","author":"RD Perrone","year":"2023","unstructured":"Perrone RD, Oberdhan D, Ouyang J, Bichet DG, Budde K, Chapman AB, Gitomer BY, Horie S, Ong ACM, Torres VE, Turner AN, Krasa H (2023) OVERTURE: a worldwide, prospective, observational study of disease characteristics in patients with ADPKD. Kidney Int Rep 8:989\u20131001. https:\/\/doi.org\/10.1016\/j.ekir.2023.02.1073","journal-title":"Kidney Int Rep"},{"key":"6652_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2215\/CJN.02410508","volume":"4","author":"D Rizk","year":"2009","unstructured":"Rizk D, Jurkovitz C, Veledar E, Bagby S, Baumgarten DA, Rahbari-Oskoui F, Steinman T, Chapman AB (2009) Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis. Clin J Am Soc Nephrol 4:560\u2013566. https:\/\/doi.org\/10.2215\/CJN.02410508","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956. https:\/\/doi.org\/10.1016\/j.kint.2020.10.047","journal-title":"Kidney Int"},{"key":"6652_CR34","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 75:1334\u20131357. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15026","journal-title":"Hypertension"},{"key":"6652_CR35","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1093\/eurheartj\/ehac328","volume":"43","author":"G de Simone","year":"2022","unstructured":"de Simone G, Mancusi C, Hanssen H, Genovesi S, Lurbe E, Parati G, Sendzikaite S, Valerio G, Di Bonito P, Di Salvo G, Ferrini M, Leeson P, Moons P, Weismann CG, Williams B (2022) Hypertension in children and adolescents. Eur Heart J 43:3290\u20133301. https:\/\/doi.org\/10.1093\/eurheartj\/ehac328","journal-title":"Eur Heart J"},{"key":"6652_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000343281","volume":"36","author":"I Helal","year":"2012","unstructured":"Helal I, Reed B, Mettler P, Mc Fann K, Tkachenko O, Yan XD, Schrier RW (2012) Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease. Am J Nephrol 36:362\u2013370. https:\/\/doi.org\/10.1159\/000343281","journal-title":"Am J Nephrol"},{"key":"6652_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder T, Schrier RW (2009) Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 5:221\u2013228. https:\/\/doi.org\/10.1038\/nrneph.2009.13","journal-title":"Nat Rev Nephrol"},{"key":"6652_CR38","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1681\/ASN.V551178","volume":"5","author":"AB Chapman","year":"1994","unstructured":"Chapman AB, Johnson AM, Gabow PA (1994) Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1178\u20131185. https:\/\/doi.org\/10.1681\/ASN.V551178","journal-title":"J Am Soc Nephrol"},{"key":"6652_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10157-022-02200-5","volume":"26","author":"N Abou Heidar","year":"2022","unstructured":"Abou Heidar N, Chehab O, Morsi RZ, Elias J, El Mouhayyar C, Kanj A, Ajam M, Haykal A, Pahuja M, Dakik H, Levine D, Imran N, Abidov A (2022) Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective. Clin Exp Nephrol 26:659\u2013668. https:\/\/doi.org\/10.1007\/s10157-022-02200-5","journal-title":"Clin Exp Nephrol"},{"key":"6652_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2215\/CJN.00080605","volume":"1","author":"KT Bae","year":"2006","unstructured":"Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP (2006) Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1:64\u201369. https:\/\/doi.org\/10.2215\/CJN.00080605","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cgh.2014.07.051","volume":"13","author":"MC Hogan","year":"2015","unstructured":"Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RW (2015) Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol 13:155-164.e156. https:\/\/doi.org\/10.1016\/j.cgh.2014.07.051","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6652_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/1097-0096(2000007\/08)28:6<277::aid-jcu2>3.0.co;2-I","volume":"28","author":"C Nicolau","year":"2000","unstructured":"Nicolau C, Torra R, Bianchi L, Vilana R, Gilabert R, Darnell A, Br\u00fa C (2000) Abdominal sonographic study of autosomal dominant polycystic kidney disease. J Clin Ultrasound 28:277\u2013282. https:\/\/doi.org\/10.1002\/1097-0096(2000007\/08)28:6%3c277::aid-jcu2%3e3.0.co;2-I","journal-title":"J Clin Ultrasound"},{"key":"6652_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/ndt\/gft437","volume":"29","author":"RL Luciano","year":"2014","unstructured":"Luciano RL, Dahl NK (2014) Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrol Dial Transplant 29:247\u2013254. https:\/\/doi.org\/10.1093\/ndt\/gft437","journal-title":"Nephrol Dial Transplant"},{"key":"6652_CR44","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/archdischild-2015-310221","volume":"101","author":"M Marlais","year":"2016","unstructured":"Marlais M, Cuthell O, Langan D, Dudley J, Sinha MD, Winyard PJ (2016) Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis. Arch Dis Child 101:1142\u20131147. https:\/\/doi.org\/10.1136\/archdischild-2015-310221","journal-title":"Arch Dis Child"},{"key":"6652_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.mbp.0000085762.28312.4a","volume":"8","author":"T Seeman","year":"2003","unstructured":"Seeman T, Dusek J, Vondrichov\u00e1 H, Kyncl M, John U, Misselwitz J, Janda J (2003) Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Press Monit 8:107\u2013110. https:\/\/doi.org\/10.1097\/01.mbp.0000085762.28312.4a","journal-title":"Blood Press Monit"},{"key":"6652_CR46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2215\/CJN.02810608","volume":"4","author":"MA Cadnapaphornchai","year":"2009","unstructured":"Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2009) Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4:820\u2013829. https:\/\/doi.org\/10.2215\/CJN.02810608","journal-title":"Clin J Am Soc Nephrol"},{"key":"6652_CR47","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00467-012-2192-y","volume":"27","author":"L Selistre","year":"2012","unstructured":"Selistre L, de Souza V, Ranchin B, Hadj-Aissa A, Cochat P, Dubourg L (2012) Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease. Pediatr Nephrol 27:1589\u20131593. https:\/\/doi.org\/10.1007\/s00467-012-2192-y","journal-title":"Pediatr Nephrol"},{"key":"6652_CR48","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00467-010-1617-8","volume":"25","author":"D Mekahli","year":"2010","unstructured":"Mekahli D, Woolf AS, Bockenhauer D (2010) Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms. Pediatr Nephrol 25:2275\u20132282. https:\/\/doi.org\/10.1007\/s00467-010-1617-8","journal-title":"Pediatr Nephrol"},{"key":"6652_CR49","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311\u20131319. https:\/\/doi.org\/10.1038\/ki.1992.195","journal-title":"Kidney Int"},{"key":"6652_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s0272-6386(12)80922-x","volume":"22","author":"VE Torres","year":"1993","unstructured":"Torres VE, Wilson DM, Hattery RR, Segura JW (1993) Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22:513\u2013519. https:\/\/doi.org\/10.1016\/s0272-6386(12)80922-x","journal-title":"Am J Kidney Dis"},{"key":"6652_CR51","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1681\/ASN.V8101560","volume":"8","author":"AM Johnson","year":"1997","unstructured":"Johnson AM, Gabow PA (1997) Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8:1560\u20131567. https:\/\/doi.org\/10.1681\/ASN.V8101560","journal-title":"J Am Soc Nephrol"},{"key":"6652_CR52","doi-asserted-by":"publisher","first-page":"e138724","DOI":"10.1172\/jci.insight.138724","volume":"5","author":"S Lavu","year":"2020","unstructured":"Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, HALT PKD and CRISP Study Investigators; Harris PC (2020) The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. JCI Insight 5:e138724. https:\/\/doi.org\/10.1172\/jci.insight.138724","journal-title":"JCI Insight"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06652-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06652-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T22:01:56Z","timestamp":1745618516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06652-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6652"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06652-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.M. is supported by the Research Foundation Flanders (FWO) under the grants G0C8920N, G060623N, and the clinical senior research grant 1804123N. D.M., B.B., and D.B. are ERKNet members. P.C.H. reports a position on the Clinical Advisory Board of Mironid, honoraria from Otsuka Pharmaceuticals and Vertex Pharmaceuticals, and other fees from Otsuka Pharmaceuticals. F.T.C. receives research funding from Natera Inc. and Otsuka Pharmaceuticals. He is Chair of the educational advisory panel at the PKD foundation in the USA. All other authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}